Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of Exenatide versus standard care in Acute Ischemic Stroke (TEXAIS)
2018-004325-88Phase 2Completed
- Sponsor
- Monash University
- Start
- Feb 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of exenatide in ischemic stroke (2 arms), sponsored by Monash University. Primary endpoint: Primary: neurological improvement at day 7. Started Feb 2019; status: completed.
02
Drugs
exenatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2018-004325-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004325-88.